English (United Kingdom)Thai (ภาษาไทย)

Tentative result for EQAI 2009

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
 

 

TRIAL 01-09-1

 
 

Control material NO.

01-09-1-1

01-09-1-2

01-09-1-3

01-09-1-4

Non treponemal test

Non Reactive

Reactive1:4

Non Reactive

Non Reactive

Treponemal test

Non Reactive

Reactive

Non Reactive

Non Reactive


TRIAL 01-09-2

Control material NO.

01-09-2-1

01-09-2-2

01-09-2-3

01-09-2-4

Non treponemal test

Reactive

Non Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Non Reactive

Non Reactive

Non Reactive

 

TRIAL 01-09-3

Control material NO.

01-09-3-1

01-09-3-2

01-09-3-3

01-09-3-4

Non treponemal test

Non Reactive

Non Reactive

Reactive

Non Reactive

Treponemal test

Non Reactive

Non Reactive

Reactive

Non Reactive

 

TRIAL 01-09-4

Control material NO.

01-09-4-1

01-09-4-2

01-09-4-3

01-09-4-4

Non treponemal test

NS

Non Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Non Reactive

Non Reactive

Non Reactive



TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM
 TRIAL 02-09-1  
 

Control material NO.

02-09-1-1

02-09-1-2

02-09-1-3

02-09-1-4

HBsAg

POSITIVE
250.9± 76.1 s/n (MEIA)

NEGATIVE
1.1± 0.3 s/n
(MEIA)

NS 4.1± 1.5 s/n
(MEIA)

NS 7.35±5.68 s/n
(MEIA)

antiHBs

NEGATIVE
0.6±0.8
mIU/ml

NEGATIVE 1.2±0.7
mIU/ml

POSITIVE 712.7±144.4
mIU/ml

POSITIVE 606.36±234.48
mIU/ml

antiHBc

POSITIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

NEGATIVE

POSITIVE

POSITIVE

Note : 02-09-1-3 and 02-09-1-4 came from the same sample.


TRIAL 02-09-2
Control material NO.

02-09-2-1

02-09-2-2

02-09-2-3

02-09-2-4

HBsAg

POSITIVE
313.29±33.73 s/n
(MEIA)

NEGATIVE
1.60±0.56 s/n
(MEIA)

NEGATIVE
1.57±0.19 s/n
(MEIA)

NEGATIVE
1.39±0.11 s/n
(MEIA)

antiHBs

NEGATIVE 0.44±0.58
mIU/ml

POSITIVE 61.19±16.62
mIU/ml

NEGATIVE 0.45±0.59
mIU/ml

NEGATIVE 0.42±0.57
mIU/ml

antiHBc

NS

POSITIVE

NEGATIVE

POSITIVE

HBeAg

NS

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

NS

NEGATIVE

POSITIVE

 

 

TRIAL 02-09-3

Control material NO.

02-09-3-1

02-09-3-2

02-09-3-3

02-09-3-4

HBsAg

NEGATIVE
0.52±0.16COI
(E-CLIA)

NEGATIVE
0.65±0.14 COI

(E-CLIA)

NEGATIVE
0.5±0.2COI

(E-CLIA)

NS 34.1±4.8 COI
(E-CLIA)

antiHBs

POSITIVE 47.9±23.8
mIU/ml*

POSITIVE 658.8±231.6
mIU/ml*

NEGATIVE
0
.6±0.8
mIU/ml*

NEGATIVE 0.5±0.9
mIU/ml*

antiHBc

POSITIVE

NEGATIVE

NEGATIVE

NEGATIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NS

NEGATIVE

NEGATIVE

NEGATIVE

* All methods

 

TRIAL 02-09-4

Control material NO.

02-09-4-1

02-09-4-2

02-09-4-3

02-09-4-4

HBsAg

NEGATIVE
0.73±0.6
(E-CLIA)

POSITIVE
8705.58±602.21

(E-CLIA)

NEGATIVE
0.87±1.2

(E-CLIA)

NEGATIVE
0.5±0.2
(E-CLIA)

antiHBs

NEGATIVE 4.18±3.16
mIU/ml

NEGATIVE 2.02±9.76
mIU/ml

NEGATIVE
0
.68±0.92
mIU/ml

POSITIVE 775.78±335.06 mIU/ml

antiHBc

POSITIVE

POSITIVE

NEGATIVE

NS

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

POSITIVE

NEGATIVE

POSITIVE

 

 

 


Copyright © 2010 Faculty of Medical Technology, Mahidol University. All Rights Reserved. Download Internet Explorer 8 Top